Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Hardeland, Rdiger ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLOROMELATONIN; AGOMELATINE; CIPROFLOXACIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; FLUCONAZOLE; FLUVOXAMINE; GG 012; GLUCAGON; GLUTAMATE RECEPTOR; HOMOCYSTEINE; INSULIN; KETOCONAZOLE; LY 156735; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR; MEXILETINE; N [2 (2,3,7,8 TETRAHYDRO 1H FURO[2,3 G]INDOL 1 YL)ETHYL]ACETAMIDE; NORFLOXACIN; PINEAL BODY HORMONE; RAMELTEON; RECOMBINANT HORMONE; RECOMBINANT MELATONIN; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR BETA; TASIMELTEON; TIK 301; UNCLASSIFIED DRUG; ZILEUTON;

ACUTE INTERMITTENT PORPHYRIA; ADRENAL CORTEX; AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AROUSAL; BINDING SITE; BIPOLAR DISORDER; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN INFECTION; BRAIN ISCHEMIA; CALCIFICATION; CARCINOGENICITY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CIRCULATION; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; DORSAL RAPHE NUCLEUS; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; ENDOMETRIUM CANCER; EXERCISE; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HORMONE DEFICIENCY; HORMONE RELEASE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INSOMNIA; INSULIN RELEASE; INSULIN RESISTANCE; LIGHT; LIVER TOXICITY; LOCUS CERULEUS; LUNG NON SMALL CELL CANCER; MAJOR DEPRESSION; MELATONIN DEFICIENCY; MENIERE DISEASE; MIGRAINE; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROBIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSESSIVE COMPULSIVE DISORDER; OSTEOPOROSIS; PAIN; PATHOPHYSIOLOGY; PHARMACOKINETICS; PINEALECTOMY; PREOPTIC NUCLEUS; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; SEIZURE; SENILE DEMENTIA; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; SLEEP QUALITY; SLEEP WAKING CYCLE; SUBSTANTIA NIGRA; SUBSTITUTION THERAPY; SUMMER; SYNAPTIC TRANSMISSION; TINNITUS; VERTIGO; WEIGHT GAIN; WITHDRAWAL SYNDROME; SLEEP DISORDER;

CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; HUMANS; MELATONIN;

EID: 84862333886     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/640389     Document Type: Review

References (235)

1. Pandi-Perumal S. R., Srinivasan V., Maestroni G. J. M., Cardinali D. P., Poeggeler B., Hardeland R., Melatoninnature's most versatile biological signal? FEBS Journal 2006 273 13 2813 2838
2. Hardeland R., Melatonin, hormone of darkness and moreoccurrence, control mechanisms, actions and bioactive metabolites Cellular and Molecular Life Sciences 2008 65 13 2001 2018
3. Hardeland R., Cardinali D. P., Srinivasan V., Spence D. W., Brown G. M., Pandi-Perumal S. R., Melatonina pleiotropic, orchestrating regulator molecule Progress in Neurobiology 2011 93 3 350 384
4. Huether G., The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates Experientia 1993 49 8 665 670 (Pubitemid 23256792)
5. Bubenik G. A., Gastrointestinal melatonin: localization, function, and clinical relevance Digestive Diseases and Sciences 2002 47 10 2336 2348 (Pubitemid 35205309)
6. Hardeland R., Poeggeler B., Melatonin beyond its classical functions The Open Physiology Journal 2008 1 1 23
7. Hardeland R., Poeggeler B., Actions of melatonin, its structural and functional analogs in the central nervous system and the significance of metabolism Central Nervous System Agents in Medicinal Chemistry 2007 7 4 289 303 (Pubitemid 350291653)
8. Carrillo-Vico A., Calvo J. R., Abreu P., Lardone P. J., Garca-Maurio S., Reiter R. J., Guerrero J. M., Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance The FASEB Journal 2004 18 3 537 539
9. Carrillo-Vico A., Guerrero J. M., Lardone P. J., Reiter R. J., A review of the multiple actions of melatonin on the immune system Endocrine 2005 27 2 189 200 (Pubitemid 41558451)
10. Huether G., Poeggeler B., Reimer A., George A., Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract Life Sciences 1992 51 12 945 953
11. Huether G., Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin Annals of the New York Academy of Sciences 1994 719 146 158 (Pubitemid 24199972)
12. Tan D. X., Manchester L. C., Hardeland R., Lopez-Burillo S., Mayo J. C., Sainz R. M., Reiter R. J., Melatonina hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin Journal of Pineal Research 2003 34 1 75 78
13. Tan D.-X., Chen L.-D., Poeggeler B., Manchester L. C., Reiter R. J., Melatonin: a potent, endogenous hydroxyl radical scavenger Endocrine Journal 1993 1 57 60
14. Reiter R. J., Acua-Castroviejo D., Tan D. X., Burkhardt S., Free radical-mediated molecular damage: mechanisms for the protective actions of melatonin in the central nervous system Annals of the New York Academy of Sciences 2001 939 200 215 (Pubitemid 32620069)
15. Reiter R. J., Tan D. X., Mayo J. C., Sainz R. M., Leon J., Czarnocki Z., Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans Acta Biochimica Polonica 2003 50 4 1129 1146 (Pubitemid 38608841)
16. Rodriguez C., Mayo J. C., Sainz R. M., Antoln I., Herrera F., Martn V., Reiter R. J., Regulation of antioxidant enzymes: a significant role for melatonin Journal of Pineal Research 2004 36 1 1 9 (Pubitemid 38130283)
17. Hardeland R., Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance Endocrine 2005 27 2 119 130 (Pubitemid 41558444)
18. Hardeland R., Neuroprotection by radical avoidance: search for suitable agents Molecules 2009 14 12 5054 5102
19. Hardeland R., Coto-Montes A., New vistas on oxidative damage and aging The Open Biology Journal 2010 3 39 52
20. Acua-Castroviejo D., Escames G., Len J., Carazo A., Khaldy H., Mitochondrial regulation by melatonin and its metabolites Advances in Experimental Medicine and Biology 2003 527 549 557 (Pubitemid 38197684)
21. Acua-Castroviejo D., Escames G., Lpez L. C., Hitos A. B., Len J., Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis Endocrine 2005 27 2 159 168 (Pubitemid 41558448)
22. Acuna-Castroviejo D., Escames G., Rodriguez M. I., Lopez L. C., Melatonin role in the mitochondrial function Frontiers in Bioscience 2007 12 3 947 963 (Pubitemid 46846869)
23. Escames G., Lpez L. C., Ortiz F., Lpez A., Garca J. A., Ros E., Acua-Castroviejo D., Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice FEBS Journal 2007 274 8 2135 2147 (Pubitemid 46588010)
24. Hardeland R., Melatonin, mitochondrial electron flux and leakage: recent findings and resolution of contradictory results Advanced Studies in Biology 2009 1 207 230
25. Lpez A., Garca J. A., Escames G., Venegas C., Ortiz F., Lpez L. C., Acua-Castroviejo D., Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production Journal of Pineal Research 2009 46 2 188 198
26. Lane N., Mitochondrial disease: powerhouse of disease Nature 2006 440 7084 600 602
27. Debray F. G., Lambert M., Mitchell G. A., Disorders of mitochondrial function Current Opinion in Pediatrics 2008 20 4 471 482
28. Koene S., Smeitink J., Mitochondrial medicine: entering the era of treatment Journal of Internal Medicine 2009 265 2 193 209
29. McFarland R., Turnbull D. M., Batteries not included: diagnosis and management of mitochondrial disease Journal of Internal Medicine 2009 265 2 210 228
30. Messner M., Hardeland R., Rodenbeck A., Huether G., Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions Journal of Pineal Research 1998 25 4 251 259 (Pubitemid 29029903)
31. Hardeland R., Melatonin: signaling mechanisms of a pleiotropic agent BioFactors 2009 35 2 183 192
32. Hardeland R., Madrid J. A., Tan D.-X., Reiter R. J., Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling Journal of Pineal Research 2012 52 2 139 166
33. Dijk D. J., Roth C., Landolt H. P., Werth E., Aeppli M., Achermann P., Borbély A. A., Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity Neuroscience Letters 1995 201 1 13 16
34. Jan J. E., Reiter R. J., Wasdell M. B., Bax M., The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders Journal of Pineal Research 2009 46 1 1 7
35. Hardeland R., New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists Neuropsychiatric Disease and Treatment 2009 5 1 341 354
36. Lewy A. J., Ahmed S., Latham Jackson J. M., Sack R. L., Melatonin shifts human circadian rhythms according to a phase-response curve Chronobiology International 1992 9 5 380 392
37. Burgess H. J., Revell V. L., Eastman C. I., A three pulse phase response curve to three milligrams of melatonin in humans Journal of Physiology 2008 586 2 639 647
38. Carlberg C., Gene regulation by melatonin Annals of the New York Academy of Sciences 2000 917 387 396
39. Brown G. M., Young S. N., Gauthier S., Tsui H., Grota L. J., Melatonin in human cerebrospinal fluid in daytime: its origin and variation with age Life Sciences 1979 25 11 929 936 (Pubitemid 10243979)
40. Reiter R. J., Richardson B. A., Some perturbations that disturb the circadian melatonin rhythm Chronobiology International 1992 9 4 314 321
41. Kunz D., Schmitz S., Mahlberg R., Mohr A., Stter C., Wolf K. J., Herrmann W. M., A new concept for melatonin deficit: on pineal calcification and melatonin excretion Neuropsychopharmacology 1999 21 6 765 772
42. Karasek M., Reiter R. J., Melatonin and aging Neuroendocrinology Letters 2002 23 1 14 16 (Pubitemid 34495375)
43. Skene D. J., Swaab D. F., Melatonin rhythmicity: effect of age and Alzheimer's disease Experimental Gerontology 2003 38 1-2 199 206 (Pubitemid 36110514)
44. Srinivasan V., Pandi-Perumal S. R., Maestroni G. J. M., Esquifino A. I., Hardeland R., Cardinali D. P., Role of melatonin in neurodegenerative diseases Neurotoxicity Research 2005 7 4 293 318
45. Wu Y. H., Fischer D. F., Kalsbeek A., Garidou-Boof M. L., van der Vliet J., van Heijningen C., Liu R. Y., Zhou J. N., Swaab D. F., Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the master clock The FASEB Journal 2006 20 11 1874 1876
46. Wu Y. H., Swaab D. F., Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease Sleep Medicine 2007 8 6 623 636 (Pubitemid 47181207)
47. Skene D. J., Vivient-Roels B., Sparks D. L., Hunsaker J. C., Pevet P., David R., Swaab D. F., Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease Brain Research 1990 528 1 170 174 (Pubitemid 20292957)
48. Uchida K., Okamoto N., Ohara K., Morita Y., Daily rhythm of serum melatonin in patients with dementia of the degenerate type Brain Research 1996 717 1-2 154 159 (Pubitemid 26153446)
49. Liu R. Y., Zhou J. N., van Heerikhuize J., Hofman M. A., Swaab D. F., Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E- 4/4 genotype Journal of Clinical Endocrinology and Metabolism 1999 84 1 323 327 (Pubitemid 29036721)
50. Mishima K., Tozawa T., Satoh K., Matsumoto Y., Hishikawa Y., Okawa M., Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking Biological Psychiatry 1999 45 4 417 421 (Pubitemid 29130438)
51. Ohashi Y., Okamoto N., Uchida K., Iyo M., Mori N., Morita Y., Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type Biological Psychiatry 1999 45 12 1646 1652 (Pubitemid 29294105)
52. Ferrari E., Fioravanti M., Magri F., Solerte S. B., Variability of interactions between neuroendocrine immunological functions physiological aging and dementia of the Alzheimer's type Annals of the New York Academy of Sciences 2000 917 582 596
53. Commentz J. C., Helmke K., Precocious puberty and decreased melatonin secretion due to a hypothalamic hamartoma Hormone Research 1995 44 6 271 275 (Pubitemid 26026494)
54. Mller H. L., Handwerker G., Wollny B., Faldum A., Srensen N., Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients Journal of Clinical Endocrinology and Metabolism 2002 87 8 3993 3996 (Pubitemid 34879560)
55. Mller H. L., Handwerker G., Gebhardt U., Faldum A., Emser A., Kolb R., Srensen N., Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness Cancer Causes and Control 2006 17 4 583 589
56. Lipton J., Megerian J. T., Kothare S. V., Cho Y. J., Shanahan T., Chart H., Ferber R., Adler-Golden L., Cohen L. E., Czeisler C. A., Pomeroy S. L., Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma Neurology 2009 73 4 323 325
57. Monteleone P., Maj M., Fusco M., Kemali D., Reiter R. J., Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics Schizophrenia Research 1992 7 1 77 84
58. Vigan D., Lissoni P., Rovelli F., Roselli M. G., Malugani F., Gavazzeni C., Conti A., Maestroni G., A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia Neuroendocrinology Letters 2001 22 2 137 141 (Pubitemid 32396392)
59. Akpinar Z., Tokgz S., Gkbel H., Okudan N., Uuz F., Yilmaz G., The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis Psychiatry Research 2008 161 2 253 257
60. Crasson M., Kjiri S., Colin A., Kjiri K., L'Hermite-Baleriaux M., Ansseau M., Legros J. J., Serum melatonin and urinary 6-sulfatoxymelatonin in major depression Psychoneuroendocrinology 2004 29 1 1 12 (Pubitemid 37298011)
61. Pandi-Perumal S. R., Moscovitch A., Srinivasan V., Spence D. W., Cardinali D. P., Brown G. M., Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine Progress in Neurobiology 2009 88 4 264 271
62. Monteleone P., Martiadis V., Maj M., Circadian rhythms and treatment implications in depression Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 7 1569 1574
63. Catapano F., Monteleone P., Fuschino A., Maj M., Kemali D., Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder Psychiatry Research 1992 44 3 217 225 (Pubitemid 23036974)
64. Aoki M., Yokota Y., Hayashi T., Kuze B., Murai M., Mizuta K., Ito Y., Disorder of the saliva melatonin circadian rhythm in patients with Meniere's disease Acta Neurologica Scandinavica 2006 113 4 256 261 (Pubitemid 43382599)
65. Rohr U. D., Herold J., Melatonin deficiencies in women Maturitas 2002 41, supplement 1 S85 S104
66. Acua-Castroviejo D., Escames G., Reiter R. J., Melatonin therapy in fibromyalgia Journal of Pineal Research 2006 40 1 98 99
67. Reiter R. J., Acuna-Castroviejo D., Tan D. X., Melatonin therapy in fibromyalgia Current Pain and Headache Reports 2007 11 5 339 342 (Pubitemid 47505864)
68. Citera G., Arias M. A., Maldonado-Cocco J. A., Lzaro M. A., Rosemffet M. G., Brusco L. I., Scheines E. J., Cardinalli D. P., The effect of melatonin in patients with fibromyalgia: a pilot study Clinical Rheumatology 2000 19 1 9 13 (Pubitemid 30123234)
69. Snchez-Barcel E. J., Mediavilla M. D., Tan D. X., Reiter R. J., Clinical uses of melatonin: evaluation of human trials Current Medicinal Chemistry 2010 17 19 2070 2095
70. Claustrat B., Loisy C., Brun J., Beorchia S., Arnaud J. L., Chazot G., Nocturnal plasma melatonin levels in migraine: a preliminary report Headache 1989 29 4 242 245 (Pubitemid 20346774)
71. Claustrat B., Brun J., Geoffriau M., Zaidan R., Mallo C., Chazot G., Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus Cephalalgia 1997 17 4 511 517 (Pubitemid 27248488)
72. Perras B., Kurowski V., Dodt C., Nocturnal melatonin concentration is correlated with illness severity in patients with septic disease Intensive Care Medicine 2006 32 4 624 625
73. Perras B., Meier M., Dodt C., Light and darkness fail to regulate melatonin release in critically ill humans Intensive Care Medicine 2007 33 11 1954 1958 (Pubitemid 47632263)
74. Srinivasan V., Pandi-Perumal S. R., Spence D. W., Kato H., Cardinali D. P., Melatonin in septic shock: some recent concepts Journal of Critical Care 2010 25 4 656 e1
75. Grin W., Grnberger W., A significant correlation between melatonin deficiency and endometrial cancer Gynecologic and Obstetric Investigation 1998 45 1 62 65 (Pubitemid 28033368)
76. Hu S., Shen G., Yin S., Xu W., Hu B., Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer Advances in Therapy 2009 26 9 886 892
77. Puy H., Deybach J. C., Baudry P., Callebert J., Touitou Y., Nordmann Y., Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks Life Sciences 1993 53 8 621 627
78. Bylesj I., Forsgren L., Wetterberg L., Melatonin and epileptic seizures in patients with acute intermittent porphyria Epileptic Disorders 2000 2 4 203 208 (Pubitemid 32157303)
79. O'Brien I. A.D., Lewin I. G., O'Hare J. P., Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy Clinical Endocrinology 1986 24 4 359 364 (Pubitemid 16103011)
80. Peschke E., Stumpf I., Bazwinsky I., Litvak L., Dralle H., Mhlbauer E., Melatonin and type 2 diabetesa possible link? Journal of Pineal Research 2007 42 4 350 358 (Pubitemid 46581659)
81. Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A., Markey S. P., Light suppresses melatonin secretion in humans Science 1980 210 4475 1267 1269 (Pubitemid 11178017)
82. Erren T. C., Reiter R. J., Defining chronodisruption Journal of Pineal Research 2009 46 3 245 247
83. Bojkowski C. J., Aldhous M. E., English J., Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man Hormone and Metabolic Research 1987 19 9 437 440 (Pubitemid 17139223)
84. Strassman R. J., Peake G. T., Qualls C. R., Lisansky E. J., A model for the study of the acute effects of melatonin in man Journal of Clinical Endocrinology and Metabolism 1987 65 5 847 852 (Pubitemid 17162629)
85. McIntyre I. M., Norman T. R., Burrows G. D., Armstrong S. M., Human melatonin suppression by light is intensity dependent Journal of Pineal Research 1989 6 2 149 156 (Pubitemid 19053502)
86. Petterborg L. J., Kjellman B. F., Thalen B. E., Wetterberg L., Effect of a 15 minute light pulse on nocturnal serum melatonin levels in human volunteers Journal of Pineal Research 1991 10 1 9 13
87. Paul M. A., Miller J. C., Love R. J., Lieberman H., Blazeski S., Arendt J., Timing light treatment for eastward and westward travel preparation Chronobiology International 2009 26 5 867 890
88. Stokkan K. A., Reiter R. J., Melatonin rhythms in Arctic urban residents Journal of Pineal Research 1994 16 1 33 36
89. Ruhayel Y., Malm G., Haugen T. B., Henrichsen T., Bjrsvik C., Grotmol T., Sther T., Malm J., Figenschau Y., Rylander L., Levine R. J., Giwercman A., Seasonal variation in serum concentrations of reproductive hormones and urinary excretion of 6-sulfatoxymelatonin in men living north and south of the Arctic Circle: a longitudinal study Clinical Endocrinology 2007 67 1 85 92 (Pubitemid 46955446)
90. Broadway J., Arendt J., Delayed recovery of sleep and melatonin rhythms after nightshift work in Antarctic winter The Lancet 1986 2 8510 813 814 (Pubitemid 16007064)
91. Yoneyama S., Hashimoto S., Honma K., Seasonal changes of human circadian rhythms in Antarctica American Journal of Physiology 1999 277 4 R1091 R1097
92. Salvesen R., Bekkelund S. I., Migraine, as compared to other headaches, is worse daring midnight-sun summer than during polar night: a questionnaire study in an arctic population Headache 2000 40 10 824 829
93. Berson D. M., Dunn F. A., Takao M., Phototransduction by retinal ganglion cells that set the circadian clock Science 2002 295 5557 1070 1073 (Pubitemid 34132236)
94. Gooley J. J., Rajaratnam S. M. W., Brainard G. C., Kronauer R. E., Czeisler C. A., Lockley S. W., Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light Science Translational Medicine 2010 2 31 31 ra33
95. Lall G. S., Revell V. L., Momiji H., Al Enezi J., Altimus C. M., Gler A. D., Aguilar C., Cameron M. A., Allender S., Hankins M. W., Lucas R. J., Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance Neuron 2010 66 3 417 428
96. Adi N., Mash D. C., Ali Y., Singer C., Shehadeh L., Papapetropoulos S., Melatonin MT 1 and MT 2 receptor expression in Parkinson's disease Medical Science Monitor 2010 16 2 BR61 BR67
97. Brunner P., Szer-Topcular N., Jockers R., Ravid R., Angeloni D., Fraschini F., Eckert A., Mller-Spahn F., Savaskan E., Pineal and cortical melatonin receptors MT 1 and MT 2 are decreased in Alzheimer's disease European Journal of Histochemistry 2006 50 4 311 316 (Pubitemid 351480093)
98. Savaskan E., Ayoub M. A., Ravid R., Angeloni D., Fraschini F., Meier F., Eckert A., Mller-Spahn F., Jockers R., Reduced hippocampal MT 2 melatonin receptor expression in Alzheimer's disease Journal of Pineal Research 2005 38 1 10 16 (Pubitemid 40139305)
99. Savaskan E., Jockers R., Ayoub M., Angeloni D., Fraschini F., Flammer J., Eckert A., Mller-Spahn F., Meyer P., The MT 2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease Current Alzheimer Research 2007 4 1 47 51 (Pubitemid 46293883)
100. Wu Y. H., Zhou J. N., van Heerikhuize J., Jockers R., Swaab D. F., Decreased MT 1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease Neurobiology of Aging 2007 28 8 1239 1247 (Pubitemid 46810065)
101. Savaskan E., Olivieri G., Meier F., Brydon L., Jockers R., Ravid R., Wirz-Justice A., Mller-Spahn F., Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients Journal of Pineal Research 2002 32 1 59 62 (Pubitemid 34123758)
102. Savaskan E., Olivieri G., Brydon L., Jockers R., Kruchi K., Wirz-Justice A., Mller-Spahn F., Cerebrovascular melatonin MT 1 -receptor alterations in patients with Alzheimer's disease Neuroscience Letters 2001 308 1 9 12 (Pubitemid 32607668)
103. Doolen S., Krause D. N., Dubocovich M. L., Duckles S. P., Melatonin mediates two distinct responses in vascular smooth muscle European Journal of Pharmacology 1998 345 1 67 69 (Pubitemid 28179472)
104. Régrigny O., Delagrange P., Scalbert E., Atkinson J., Lartaud-Idjouadiene I., Melatonin improves cerebral circulation security margin in rats American Journal of Physiology 1998 275 1 H139 H144
105. Dubocovich M. L., Markowska M., Functional MT 1 and MT 2 melatonin receptors in mammals Endocrine 2005 27 2 101 110
106. de la Torre J. C., Stefano G. B., Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide Brain Research Reviews 2000 34 3 119 136
107. Furio A. M., Brusco L. I., Cardinali D. P., Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study Journal of Pineal Research 2007 43 4 404 409 (Pubitemid 47512272)
108. Riemersma-van der Lek R. F., Swaab D. F., Twisk J., Hol E. M., Hoogendijk W. J. G., van Someren E. J. W., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial Journal of the American Medical Association 2008 299 22 2642 2655 (Pubitemid 351831594)
109. Cardinali D. P., Furio A. M., Brusco L. I., Clinical aspects of melatonin intervention in Alzheimer's disease progression Current Neuropharmacology 2010 8 3 218 227
110. Mssig K., Staiger H., MacHicao F., Hring H. U., Fritsche A., Genetic variants in MTNR1B affecting insulin secretion Annals of Medicine 2010 42 6 387 393
111. Shieh J. M., Wu H. T., Cheng K. C., Cheng J. T., Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKC -Akt-GSK3 pathway in hepatic cells Journal of Pineal Research 2009 47 4 339 344
112. Ha E., Choe B. K., Jung K. H., Yoon S. H., Park H. J., Park H. K., Yim S. V., Chung J. H., Bae H. S., Nam M., Baik H. H., Hong S. J., Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population Journal of Pineal Research 2005 39 2 201 205 (Pubitemid 41140760)
113. Mrocz M., Czibula., Grzer Z. B., Szécsényi A., lmos P. Z., Rask I., Illés T., Association study of BMP4, IL6, Leptin, MMP3, and MTNR1B gene promoter polymorphisms and adolescent idiopathic scoliosis Spine 2011 36 2 E123 E130
114. Li C., Shi Y., You L., Wang L., Chen Z.-J., Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome Gynecologic and Obstetric Investigation 2011 72 2 130 134
115. Park H. J., Park J. K., Kim S. K., Cho A.-R., Kim J. W., Yim S.-V., Chung J.-H., Association of polymorphism in the promoter of the melatonin receptor 1A gene with schizophrenia and with insomnia symptoms in schizophrenia patients Journal of Molecular Neuroscience 2011 45 2 304 308
116. Terracciano A., Tanaka T., Sutin A. R., Sanna S., Deiana B., Lai S., Uda M., Schlessinger D., Abecasis G. R., Ferrucci L., Costa P. T., Genome-wide association scan of trait depression Biological Psychiatry 2010 68 9 811 817
117. Garriock H. A., Kraft J. B., Shyn S. I., Peters E. J., Yokoyama J. S., Jenkins G. D., Reinalda M. S., Slager S. L., McGrath P. J., Hamilton S. P., A genomewide association study of citalopram response in major depressive disorder Biological Psychiatry 2010 67 2 133 138
118. Schaumberg D. A., Chasman D., Morrison M. A., Adams S. M., Guo Q., Hunter D. J., Hankinson S. E., DeAngelis M. M., Prospective study of common variants in the retinoic acid receptor-related orphan receptor gene and risk of neovascular age-related macular degeneration Archives of Ophthalmology 2010 128 11 1462 1471
119. Silveira A. C., Morrison M. A., Ji F., Xu H., Reinecke J. B., Adams S. M., Arneberg T. M., Janssian M., Lee J. E., Yuan Y., Schaumberg D. A., Kotoula M. G., Tsironi E. E., Tsiloulis A. N., Chatzoulis D. Z., Miller J. W., Kim I. K., Hageman G. S., Farrer L. A., Haider N. B., DeAngelis M. M., Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach Vision Research 2010 50 7 698 715
120. McGrath C. L., Glatt S. J., Sklar P., Le-Niculescu H., Kuczenski R., Doyle A. E., Biederman J., Mick E., Faraone S. V., Niculescu A. B., Tsuang M. T., Evidence for genetic association of RORB with bipolar disorder BMC Psychiatry 2009 9, article 70
121. Von Gall C., Stehle J. H., Weaver D. R., Mammalian melatonin receptors: molecular biology and signal transduction Cell and Tissue Research 2002 309 1 151 162 (Pubitemid 34744037)
122. Stehle J. H., von Gall C., Korf H. W., Melatonin: a clock-output, a clock-input Journal of Neuroendocrinology 2003 15 4 383 389 (Pubitemid 36395236)
123. Arendt J., Skene D. J., Melatonin as a chronobiotic Sleep Medicine Reviews 2005 9 1 25 39 (Pubitemid 40092916)
124. Challet E., Minireview: entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals Endocrinology 2007 148 12 5648 5655 (Pubitemid 350146137)
125. Saper C. B., Scammell T. E., Lu J., Hypothalamic regulation of sleep and circadian rhythms Nature 2005 437 7063 1257 1263 (Pubitemid 41568665)
126. Fuller P. M., Gooley J. J., Saper C. B., Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback Journal of Biological Rhythms 2006 21 6 482 493 (Pubitemid 44706829)
127. de Gennaro L., Ferrara M., Sleep spindles: an overview Sleep Medicine Reviews 2003 7 5 423 440 (Pubitemid 37221986)
128. Haimov I., Laudon M., Zisapel N., Souroujon M., Nof D., Shlitner A., Herer P., Tzischinsky O., Lavie P., Sleep disorders and melatonin rhythms in elderly people British Medical Journal 1994 309 6948 167
129. Zisapel N., The use of melatonin for the treatment of insomnia Biological Signals and Receptors 1999 8 1-2 84 89 (Pubitemid 29132388)
130. Haimov I., Melatonin rhythm abnormalities and sleep disorders in the elderly CNS Spectrums 2001 6 6 502 506 (Pubitemid 32622746)
131. Lehmann E. D., Cockerell O. C., Rudge P., Somnolence associated with melatonin deficiency after pinealectomy The Lancet 1996 347 8997 323 (Pubitemid 26041050)
132. Kocher L., Brun J., Borson-Chazot F., Gonnaud P. M., Claustrat B., Increased REM sleep associated with melatonin deficiency after pinealectomy: a case study Chronobiology International 2006 23 4 889 901 (Pubitemid 44186974)
133. Perils M. L., Giles D. E., Buysse D. J., Tu X., Kupfer D. J., Self-reported sleep disturbance as a prodromal symptom in recurrent depression Journal of Affective Disorders 1997 42 2-3 209 212 (Pubitemid 27170166)
134. Srinivasan V., Pandi-Perumal S. R., Trakht I., Spence D. W., Hardeland R., Poeggeler B., Cardinali D. P., Pathophysiology of depression: role of sleep and the melatonergic system Psychiatry Research 2009 165 3 201 214
135. Pandi-Perumal S. R., Trakht I., Srinivasan V., Spence D. W., Poeggeler B., Hardeland R., Cardinali D. P., The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives World Journal of Biological Psychiatry 2009 10 4 342 354
136. Wilhelmsen M., Amirian I., Reiter R. J., Rosenberg J., Ggenur I., Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies Journal of Pineal Research 2011 51 3 270 277
137. Larson J., Jessen R. E., Uz T., Arslan A. D., Kurtuncu M., Imbesi M., Manev H., Impaired hippocampal long-term potentiation in melatonin MT 2 receptor-deficient mice Neuroscience Letters 2006 393 1 23 26 (Pubitemid 41739647)
138. Weil Z. M., Hotchkiss A. K., Gatien M. L., Pieke-Dahl S., Nelson R. J., Melatonin receptor (MT 1) knockout mice display depression-like behaviors and deficits in sensorimotor gating Brain Research Bulletin 2006 68 6 425 429 (Pubitemid 43177577)
139. Reiter R. J., Tan D. X., Kim S. J., Manchester L. C., Qi W., Garcia J. J., Cabrera J. C., El-Sokkary G., Rouvier-Garay V., Augmentation of indices of oxidative damage in life-long melatonin-deficient rats Mechanisms of Ageing and Development 1999 110 3 157 173 (Pubitemid 29486734)
140. Korkmaz A., Reiter R. J., Topal T., Manchester L. C., Oter S., Tan D. X., Melatonin: an established antioxidant worthy of use in clinical trials Molecular Medicine 2009 15 1-2 43 50
141. Galano A., Tan D. X., Reiter R. J., Melatonin as a natural ally against oxidative stress: a physicochemical examination Journal of Pineal Research 2011 51 1 1 16
142. Baydas G., Ferit Gursu M., Cikim G., Canpolat S., Yasar A., Canatan H., Kelestimur H., Effects of pinealectomy on the levels and the circadian rhythm of plasma homocysteine in rats Journal of Pineal Research 2002 33 3 151 155
143. Manev H., Uz T., Kharlamov A., Joo J. Y., Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats The FASEB Journal 1996 10 13 1546 1551 (Pubitemid 26384452)
144. Coto-Montes A., Hardeland R., La importancia del ritmo circadiano y de la melatonina para evitar el estrés oxidativo. Implicaciones en la investigacin del trabajo a turnos rotatorio Vigilia-Sueo 2000 12 133 146
145. Navara K. J., Nelson R. J., The dark side of light at night: physiological, epidemiological, and ecological consequences Journal of Pineal Research 2007 43 3 215 224 (Pubitemid 47353006)
146. Shigenaga M. K., Hagen T. M., Ames B. N., Oxidative damage and mitochondrial decay in aging Proceedings of the National Academy of Sciences of the United States of America 1994 91 23 10771 10778 (Pubitemid 24349567)
147. Liu J., Mori A., Stress, aging, and brain oxidative damage Neurochemical Research 1999 24 11 1479 1497 (Pubitemid 29505958)
148. Petropoulos I., Friguet B., Maintenance of proteins and aging: the role of oxidized protein repair Free Radical Research 2006 40 12 1269 1276 (Pubitemid 44698276)
149. Chen J. H., Hales C. N., Ozanne S. E., DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Research 2007 35 22 7417 7428
150. Martien S., Abbadie C., Acquisition of oxidative DNA damage during senescence: the first step toward carcinogenesis? Annals of the New York Academy of Sciences 2007 1119 1 51 63 (Pubitemid 350191228)
151. Pamplona R., Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity Biochimica et Biophysica Acta 2008 1777 10 1249 1262
152. Khansari N., Shakiba Y., Mahmoudi M., Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer Recent Patents on Inflammation and Allergy Drug Discovery 2009 3 1 73 80
153. Poeggeler B., Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy Endocrine 2005 27 2 201 212
154. Rodrguez M. I., Escames G., Lpez L. C., Lpez A., Garca J. A., Ortiz F., Snchez V., Romeu M., Acua-Castroviejo D., Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice Experimental Gerontology 2008 43 8 749 756
155. Guerrero J. M., Reiter R. J., Melatonin-immune system relationships Current Topics in Medicinal Chemistry 2002 2 2 167 179
156. Szczepanik M., Melatonin and its influence on immune system Journal of Physiology and Pharmacology 2007 58, supplement 6 115 124
157. Swain S. L., Nikolich-Zugich J., Key research opportunities in immune
158. Streit W. J., Xue Q. S., The brain's aging immune system Aging and Disease 2010 1 254 261
159. Fulop T., Larbi A., Kotb R., de Angelis F., Pawelec G., Aging, immunity, and cancer Discovery Medicine 2011 11 61 537 550
160. Blask D. E., Sauer L. A., Dauchy R. T., Holowachuk E. W., Ruhoff M. S., Kopff H. S., Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events Cancer Research 1999 59 18 4693 4701 (Pubitemid 29428978)
161. Petranka J., Baldwin W., Biermann J., Jayadev S., Barrett J. C., Murphy E., The oncostatic action of melatonin in an ovarian carcinoma cell line Journal of Pineal Research 1999 26 3 129 136 (Pubitemid 29183115)
162. Blask D. E., Sauer L. A., Dauchy R. T., Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy Current Topics in Medicinal Chemistry 2002 2 2 113 132
163. Blask D. E., Dauchy R. T., Sauer L. A., Krause J. A., Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin Carcinogenesis 2004 25 6 951 960 (Pubitemid 38886081)
164. Dauchy R. T., Dauchy E. M., Davidson L. K., Krause J. A., Lynch D. T., Tirrell P. C., Tirrell R. P., Sauer L. A., van der Riet P., Blask D. E., Inhibition of fatty acid transport and proliferative activity in tissue-isolated human squamous cell cancer xenografts perfused in situ with melatonin or eicosapentaenoic or conjugated linoleic acids Comparative Medicine 2007 57 4 377 382 (Pubitemid 351785204)
165. Hill S. M., Blask D. E., Xiang S., Yuan L., Mao L., Dauchy R. T., Dauchy E. M., Frasch T., Duplesis T., Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer Journal of Mammary Gland Biology and Neoplasia 2011 16 3 235 245
166. Viswanathan A. N., Hankinson S. E., Schernhammer E. S., Night shift work and the risk of endometrial cancer Cancer Research 2007 67 21 10618 10622 (Pubitemid 350070839)
167. Schernhammer E. S., Berrino F., Krogh V., Secreto G., Micheli A., Venturelli E., Grioni S., Sempos C. T., Cavalleri A., Schnemann H. J., Strano S., Muti P., Urinary 6-sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort Cancer Epidemiology Biomarkers and Prevention 2010 19 3 729 737
168. Peschke E., Melatonin, endocrine pancreas and diabetes Journal of Pineal Research 2008 44 1 26 40 (Pubitemid 350231107)
169. Contreras-Alcantara S., Baba K., Tosini G., Removal of melatonin receptor type 1 induces insulin resistance in the mouse Obesity 2010 18 9 1861 1863
170. Rasmussen D. D., Boldt B. M., Wilkinson C. W., Yellon S. M., Matsumoto A. M., Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels Endocrinology 1999 140 2 1009 1012 (Pubitemid 29058243)
171. Wolden-Hanson T., Mitton D. R., McCants R. L., Yellon S. M., Wilkinson C. W., Matsumoto A. M., Rasmussen D. D., Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat Endocrinology 2000 141 2 487 497 (Pubitemid 32250470)
172. Prunet-Marcassus B., Desbazeille M., Bros A., Louche K., Delagrange P., Renard P., Casteilla L., Pénicaud L., Melatonin reduces body weight gain in sprague dawley rats with diet-induced obesity Endocrinology 2003 144 12 5347 5352 (Pubitemid 37476063)
173. Ladizesky M. G., Boggio V., Albornoz L. E., Castrilln P. O., Mautalen C., Cardinali D. P., Melatonin increases oestradiol-induced bone formation in ovariectomized rats Journal of Pineal Research 2003 34 2 143 151 (Pubitemid 36255923)
174. She M., Deng X., Guo Z., Laudon M., Hu Z., Liao D., Hu X., Luo Y., Shen Q., Su Z., Yin W., NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats Pharmacological Research 2009 59 4 248 253
175. Ros-Lugo M. J., Cano P., Jiménez-Ortega V., Fernndez-Mateos M. P., Scacchi P. A., Cardinali D. P., Esquifino A. I., Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats Journal of Pineal Research 2010 49 4 342 348
176. Oxenkrug G. F., Summergrad P., Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats Annals of the New York Academy of Sciences 2010 1199 114 120
177. Turner P. L., Mainster M. A., Circadian photoreception: ageing and the eye's important role in systemic health British Journal of Ophthalmology 2008 92 11 1439 1444
178. Bass J., Takahashi J. S., Circadian integration of metabolism and energetics Science 2010 330 6009 1349 1354
179. Garaulet M., Ordovs J. M., Madrid J. A., The chronobiology, etiology and pathophysiology of obesity International Journal of Obesity 2010 34 12 1667 1683
180. Sack R. L., Lewy A. J., Blood M. L., Stevenson J., Keith L. D., Melatonin administration to blind people: phase advances and entrainment Journal of Biological Rhythms 1991 6 3 249 261
181. Sack R. L., Lewy A. J., Blood M. L., Keith L. D., Nakagawa H., Circadian rhythm abnormalities in totally blind people: incidence and clinical significance Journal of Clinical Endocrinology and Metabolism 1992 75 1 127 134
182. Lockley S. W., Skene D. J., James K., Thapan K., Wright J., Arendt J., Melatonin administration can entrain the free-running circadian system of blind subjects Journal of Endocrinology 2000 164 1 R1 R6
183. Sack R. L., Brandes R. W., Kendall A. R., Lewy A. J., Entrainment of free-running circadian rhythms by melatonin in blind people The New England Journal of Medicine 2000 343 15 1070 1077
184. Emens J. S., Lewy A. J., Lefler B. J., Sack R. L., Relative coordination to unknown weak zeitgebers in free-running blind individuals Journal of Biological Rhythms 2005 20 2 159 167 (Pubitemid 40389162)
185. Emens J., Lewy A. J., Laurie A. L., Songer J. B., Rest-activity cycle and melatonin rhythm in blind free-runners have similar periods Journal of Biological Rhythms 2010 25 5 381 384
186. Hayakawa T., Uchiyama M., Kamei Y., Shibui K., Tagaya H., Asada T., Okawa M., Urata J., Takahashi K., Clinical analyses of sighted patients with non-24-hour sleep-wake syndrome: a study of 57 consecutively diagnosed cases Sleep 2005 28 8 945 952 (Pubitemid 41170929)
187. Sack R. L., Auckley D., Auger R. R., Carskadon M. A., Wright K. P., Vitiello M. V., Zhdanova I. V., Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm: an American Academy of Sleep Medicine review Sleep 2007 30 11 1484 1501 (Pubitemid 350036974)
188. Echizenya M., Iwaki S., Suda H., Shimizu T., Paradoxical reactions to hypnotic agents in adolescents with free-running disorder Psychiatry and Clinical Neurosciences 2009 63 3 428
189. Archer S. N., Carpen J. D., Gibson M., Lim G. H., Johnston J. D., Skene D. J., Von Schantz M., Polymorphism in the PER3 promoter associates with diurnal preference and delayed sleep phase disorder Sleep 2010 33 5 695 701
190. Aschoff J., Wever R., Human circadian rhythms: a multioscillatory system Federation Proceedings 1976 35 12 2326 2332
191. Halberg F., Carandente F., Cornelissen G., Katinas G. S., Glossary of chronobiology Chronobiologia 1977 4, supplement 1
192. Srinivasan V., Smits M., Spence W., Lowe A., Kayumov L., Pandi-Perumal S., Parry B., Cardinali D., Melatonin in mood disorders World Journal of Biological Psychiatry 2006 7 3 138 151 (Pubitemid 44137014)
193. McClung C. A., Circadian genes, rhythms and the biology of mood disorders Pharmacology and Therapeutics 2007 114 2 222 232 (Pubitemid 46561535)
194. Lewy A. J., Rough J. N., Songer J. B., Mishra N., Yuhas K., Emens J. S., The phase shift hypothesis for the circadian component of winter depression Dialogues in Clinical Neuroscience 2007 9 3 291 300 (Pubitemid 350003872)
195. Westrin A., Lam R. W., Seasonal affective disorder: a clinical update Annals of Clinical Psychiatry 2007 19 4 239 246 (Pubitemid 350208794)
196. Lewy A. J., Melatonin and human chronobiology Cold Spring Harbor Symposia on Quantitative Biology 2007 72 623 636
197. Hardeland R., Investigational melatonin receptor agonists Expert Opinion on Investigational Drugs 2010 19 6 747 764
198. Lamont E. W., Legault-Coutu D., Cermakian N., Boivin D. B., The role of circadian clock genes in mental disorders Dialogues in Clinical Neuroscience 2007 9 3 333 342 (Pubitemid 350010682)
199. Agez L., Laurent V., Guerrero H. Y., Pévet P., Masson-Pévet M., Gauer F., Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat Journal of Pineal Research 2009 46 1 95 105
200. Dinet V., Ansari N., Torres-Farfan C., Korf H. W., Clock gene expression in the retina of melatonin-proficient (C3H) and melatonin-deficient (C57BL) mice Journal of Pineal Research 2007 42 1 83 91 (Pubitemid 44924329)
201. Dinet V., Korf H. W., Impact of melatonin receptors on pCREB and clock-gene protein levels in the murine retina Cell and Tissue Research 2007 330 1 29 34 (Pubitemid 47438594)
202. Torres-Farfan C., Sern-Ferré M., Dinet V., Korf H. W., Immunocytochemical demonstration of day/night changes of clock gene protein levels in the murine adrenal gland: differences between melatonin-proficient (C3H) and melatonin-deficient (C57BL) mice Journal of Pineal Research 2006 40 1 64 70
203. Imbesi M., Arslan A. D., Yildiz S., Sharma R., Gavin D., Tun N., Manev H., Uz T., The melatonin receptor MT 1 is required for the differential regulatory actions of melatonin on neuronal clock gene expression in striatal neurons in vitro Journal of Pineal Research 2009 46 1 87 94
204. Imbesi M., Uz T., Manev H., Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons Journal of Neural Transmission 2008 115 11 1495 1499
205. Akaboshi S., Inoue Y. I., Kubota N., Takeshita K., Case of a mentally retarded child with non-24 hour sleep-wake syndrome caused by deficiency of melatonin secretion Psychiatry and Clinical Neurosciences 2000 54 3 379 380 (Pubitemid 30431867)
206. Leu-Semenescu S., Arnulf I., Decaix C., Moussa F., Clot F., Boniol C., Touitou Y., Levy R., Vidailhet M., Roze E., Sleep and rhythm consequences of a genetically induced loss of serotonin Sleep 2010 33 3 307 314
207. Potocki L., Glaze D., Tan D. X., Park S. S., Kashork C. D., Shaffer L. G., Reiter R. J., Lupski J. R., Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome Journal of Medical Genetics 2000 37 6 428 433 (Pubitemid 30386734)
208. de Leersnyder H., Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment Trends in Endocrinology and Metabolism 2006 17 7 291 298 (Pubitemid 44287474)
209. Vilboux T., Ciccone C., Blancato J. K., Cox G. F., Deshpande C., Introne W. J., Gahl W. A., Smith A. C.M., Huizing M., Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected smith-magenis syndrome without the 17p11.2 deletion PLoS ONE 2011 6 8
210. Sanford E. F., Bermudez-Wagner K., Jeng L. J.B., Rauen K. A., Slavotinek A. M., Congenital diaphragmatic hernia in Smith-Magenis syndrome: a possible locus at chromosome 17p11.2 American Journal of Medical Genetics Part A 2011 155 11 2816 2820
211. de Leersnyder H., Claustrat B., Munnich A., Verloes A., Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome Molecular and Cellular Endocrinology 2006 252 1-2 88 91
212. Carpizo R., Martnez A., Mediavilla D., Gonzlez M., Abad A., Snchez-Barcel E. J., Smith-Magenis syndrome: a case report of improved sleep after treatment with 1-adrenergic antagonists and melatonin Journal of Pediatrics 2006 149 3 409 411 (Pubitemid 44308427)
213. Claustrat B., Brun J., Chazot G., The basic physiology and pathophysiology of melatonin Sleep Medicine Reviews 2005 9 1 11 24 (Pubitemid 40092915)
214. Hardeland R., Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders Current Opinion in Investigational Drugs 2009 10 7 691 701
215. Pandi-Perumal S. R., Srinivasan V., Poeggeler B., Hardeland R., Cardinali D. P., Drug Insight: the use of melatonergic agonists for the treatment of insomniafocus on ramelteon Nature Clinical Practice Neurology 2007 3 4 221 228 (Pubitemid 46605272)
216. Pittendrigh C. S., Daan S., A functional analysis of circadian pacemakers in nocturnal rodents. IV. Entrainment: pacemaker as clock Journal of Comparative Physiology A 1976 106 3 291 331
217. André E., Conquet F., Steinmayr M., Stratton S. C., Porciatti V., Becker-André M., Disruption of retinoid-related orphan receptor changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice The EMBO Journal 1998 17 14 3867 3877 (Pubitemid 28333973)
218. Masana M. I., Sumaya I. C., Becker-André M., Dubocovich M. L., Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the ROR knockout American Journal of Physiology 2007 292 6 R2357 R2367
219. Karim A., Tolbert D., Cao C., Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT 1 and MT 2 melatonin receptor agonist indicated for treatment of insomnia Journal of Clinical Pharmacology 2006 46 2 140 148 (Pubitemid 43146444)
220. Hardeland R., Poeggeler B., Srinivasan V., Trakht I., Pandi-Perumal S. R., Cardinali D. P., Melatonergic drugs in clinical practice Arzneimittelforschung 2008 58 1 1 10 (Pubitemid 351220148)
221. Pandi-Perumal S. R., Spence D. W., Verster J. C., Srinivasan V., Brown G. M., Cardinali D. P., Hardeland R., Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications Journal of Central Nervous System Disease 2011 3 51 65
222. Erman M., Seiden D., Zammit G., Sainati S., Zhang J., An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia Sleep Medicine 2006 7 1 17 24 (Pubitemid 43033540)
223. Roth T., Seiden D., Sainati S., Wang-Weigand S., Zhang J., Zee P., Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia Sleep Medicine 2006 7 4 312 318 (Pubitemid 43792892)
224. Richardson G. S., Zammit G., Wang-Weigand S., Zhang J., Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study Journal of Clinical Psychiatry 2009 70 4 467 476
225. Mayer G., Wang-Weigand S., Roth-Schechter B., Lehmann R., Staner C., Partinen M., Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia Sleep 2009 32 3 351 360
226. Uchiyama M., Hamamura M., Kuwano T., Nagata H., Hashimoto T., Ogawa A., Uchimura N., Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia Sleep Medicine 2011 12 2 127 133
227. Srinivasan V., Pandi-Perumal S. R., Trahkt I., Spence D. W., Poeggeler B., Hardeland R., Cardinali D. P., Melatonin and melatonergic drugs on sleep: possible mechanisms of action International Journal of Neuroscience 2009 119 6 821 846
228. Millan M. J., Gobert A., Lejeune F., Dekeyne A., Newman-Tancredi A., Pasteau V., Rivet J. M., Cussac D., The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways Journal of Pharmacology and Experimental Therapeutics 2003 306 3 954 964 (Pubitemid 37025301)
229. Bourin M., Mocar E., Porsolt R., Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors Journal of Psychiatry and Neuroscience 2004 29 2 126 133 (Pubitemid 38570217)
230. Pandi-Perumal S. R., Srinivasan V., Cardinali D. P., Monti J. M., Could agomelatine be the ideal antidepressant? Expert Review of Neurotherapeutics 2006 6 11 1595 1608 (Pubitemid 44904007)
231. Howland R. H., Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults Neuropsychiatric Disease and Treatment 2009 5 1 563 576
232. Agomelatine: new drug: adverse effects and no proven efficacy Prescrire International 2009 18 104 241 245
233. Howland R. H., A benefit-risk assessment of agomelatine in the treatment of major depression Drug Safety 2011 34 9 709 731
234. Howland R. H., Publication bias and outcome reporting bias: agomelatine as a case example Journal of Psychosocial Nursing and Mental Health Services 2011 49 9 11 14
235. Willis G. L., Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process Reviews in the Neurosciences 2008 19 4-5 245 316